TITLE

Nocturnal Recovery of Gastric Acid Secretion With Twice-Daily Dosing of Proton Pump Inhibitors

AUTHOR(S)
Peghini, Paolo L.; Katz, Philip O.; Bracy, Nicole A.; Castell, Donald O.
PUB. DATE
May 1998
SOURCE
American Journal of Gastroenterology;May1998, Vol. 93 Issue 5, p763
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: It is our experience that many patients treated with proton pump inhibitors (PPI) b.i.d, recover acid secretion during the night. Our aim was to assess the efficacy of omeprazole and lansoprazole b.i.d. on nocturnal gastric acidity. Methods: Three groups were studied with intragastric pH monitoring. Group 1 consisted of 17 patients with gastroesophageal reflux disease (GERD) taking omeprazole 20 mg b.i.d. Group 2 was 16 mule volunteers taking omeprazole 20 mg b.i.d, and Group 3 comprised 12 volunteers taking lansopraole 30 mg b.i.d. Results: The percentages of time that subjects had pH < 4 were lower during supine than upright periods in Groups 1 and 3 (P < 0.01). Recovery of nocturnal acid secretion lasting > 1 h, termed acid breakthrough, occurred in three-fourths of all individuals within 12 h from intake of the evening dose of PPI. Median time to acid breakthrough for the whole group was 7.5 h. Conclusion: Nocturnal acid breakthrough occurs in a majority of patients and normal volunteers taking PPI b.i.d..
ACCESSION #
16070933

 

Related Articles

  • Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease. Kinoshita, Yoshikazu; Kazumori, Hideaki; Ishihara, Shunji // Journal of Gastroenterology;Mar2006, Vol. 41 Issue 3, p286 

    The article focuses on the study regarding the treatment of proton pump inhibitor-resistant patients with gastroesphageal reflux disease. According to the article, drugs that raise the intragastric potential of hydrogen level above 4.0 are effective for the treatment of gastroesophageal reflux...

  • Managing Heartburn Symptoms in Patients Treated With Proton Pump Inhibitors.  // Pharmacy Today;Oct2006, Vol. 12 Issue 10, p1 

    The article focuses on the management of heartburn symptoms in patients under proton pump inhibitor treatment. Patients usually describe heartburn as a feeling of burning discomfort from the stomach of lower chest and travels towards the neck or throat. It is the most evident in gastroesophageal...

  • Stability of Gastric Secretory Inhibition During 6-Month Treatment With Omeprazole in Patients With Gastroesophageal Reflux Disease. Tefera, Solomon; Hatlebakk, Jan Gunnar; Berstad, Arnold // American Journal of Gastroenterology;Apr2001, Vol. 96 Issue 4, p969 

    OBJECTIVE: A trend toward relapse of reflux symptoms and esophagitis during long-term treatment with proton pump inhibitors has been reported. The purpose of this study was to evaluate the existence of tachyphylaxia to the effect of proton pump inhibitors on gastric acidity and gastroesophageal...

  • Reflux Esophagitis: Healed! Now What? Romero, Yvonne; Egan, Laurence J.; Muray, Joseph A. // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p337 

    Offers observation on reflux esophagitis. Number of Americans who experience heartburn annually; Information on proton pump inhibitor; Primary inactivation pathway for omeprazole.

  • Acid Inhibition in GERD–How Much is Enough? Achem, Sami R. // American Journal of Gastroenterology;Jun2004, Vol. 99 Issue 6, p997 

    Gastric acid plays a fundamental role in the development of mucosal injury and symptoms in gastro-esophageal reflux disease(GERD). In this issue of theJournal, Milkes et al report the inability of proton pump inhibitor (PPIs) therapy to“normalize” 24-hour intraesophageal pH...

  • Barrett's Esophagus--What Should I Know About It?  // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2120 

    Provides information on Barrett's esophagus. Disadvantage of too much stomach acid; Association of gastroesophageal reflux disease with Barrett's esophagus; Use of proton pump inhibitors for treating Barrett's esophagus.

  • Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Mainie, I.; Tutuian, R.; Shay, S.; Vela, M.; Zhang, X.; Sifrim, D.; Castell, D. O. // Gut;Oct2006, Vol. 55 Issue 10, p1398 

    Background and aims: Empiric proton pump inhibitor (PPI) trials have become increasingly popular leading to gastroenterologists frequently evaluating gastro-oesophageal reflux disease (GORD) patients only after they have ‘failed’ PPI therapy. Combined multichannel intraluminal...

  • Editorial: Bringing GERD Management up to PAR-2. Souza, Rhonda F. // American Journal of Gastroenterology;Sep2010, Vol. 105 Issue 9, p1944 

    Proton pump inhibitors (PPIs) are extremely effective for mucosal healing of reflux esophagitis, but less so for relieving the symptom of heartburn. PPIs block the secretion of gastric acid, the caustic effects of which have been assumed to be the primary culprit in the pathogenesis of reflux...

  • Why Is the High Grade Inhibition of Gastric Acid Secretion Afforded by Proton Pump Inhibitors Often Required for Healing of Reflux Esophagitis? An Epithelial Perspective. Orlando, Roy C. // American Journal of Gastroenterology;Sep1996, Vol. 91 Issue 9, p1692 

    The effectiveness of proton pump inhibitors in the treatment of reflux esophagitis is undisputed. The same is true for the mechanism by which their beneficial effects are achieved and, that is, by potent suppression of gastric acid secretion. The underappreciated side of the story is not that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics